过去一年中添加的文章,按日期排序
Genetics and Pathophysiological Mechanisms of Lipoprotein (a)‐Associated Cardiovascular Risk
AS Volgman, ML Koschinsky, A Mehta… - … of the American Heart …, 2024 - Am Heart Assoc
22 天前 - … In this study, the composite genotype termed interleukin- 1… a higher risk of coronary
artery disease compared with the … artery disease was identified in patients with interleukin- 1(…
artery disease compared with the … artery disease was identified in patients with interleukin- 1(…
Repair of the infarcted heart: cellular effectors, molecular mechanisms and therapeutic opportunities
I Hilgendorf, S Frantz, NG Frangogiannis - Circulation Research, 2024 - Am Heart Assoc
33 天前 - … , leading to upregulation of cytokines (such as interleukin-1, TNF-α [tumor necrosis
… targets to attenuate heart failure progression and inhibit arrhythmia generation in patients …
… targets to attenuate heart failure progression and inhibit arrhythmia generation in patients …
Colchicine in acute heart failure: Rationale and design of a randomized double‐blind placebo‐controlled trial (COLICA)
D Pascual‐Figal, J Núñez Villota… - … of Heart Failure - Wiley Online Library
34 天前 - … pericarditis and ischaemic heart disease, may target this inflammatory response. …
interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure …
interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure …
POS1390 SINGLE-CELL PROFILING IDENTIFIES PERIPHERAL IMMUNE SIGNATURE OF CORONARY ARTERY DISEASE IN SLE PATIENTS
C LI, L Osmani, J Gu, H Zhao, I Kang, R Bucala… - 2024 - ard.bmj.com
37 天前 - … In contrast to the pathogenesis of interleukin-1 in CAD in … key role in contributing to
cardiovascular inflammation. The chemokine … targets to decrease cardiovascular risk in SLE. …
cardiovascular inflammation. The chemokine … targets to decrease cardiovascular risk in SLE. …
DIFFERENTIAL TRANSCRIPTOME ANALYSIS OF IN VITRO MUTAGENIZED FUSARIUM TOLERANT PLANTS OF GINGER (Zingiber officinale Rosc.) cv. HIMGIRI
S POOJA - 2024 - krishikosh.egranth.ac.in
42 天前 - … panacea for treating arthritis, heart diseases, cancer, diarrhea, and … -coil, and
Toll/Interleukin-1 receptors were identified in … to disease resistance to serve as potential targets for …
Toll/Interleukin-1 receptors were identified in … to disease resistance to serve as potential targets for …
A (cholesterol) crystal clear path to inflammasome activation in atherosclerosis
X Li, T Sallam - Journal of Lipid Research, 2024 - ASBMB
66 天前 - … and release of proinflammatory cytokines such as interleukin 1 beta and interleukin
18 ( … authors use an RNA interference approach targeting a key transporter of cholesterol …
18 ( … authors use an RNA interference approach targeting a key transporter of cholesterol …
Bioinformatics analysis of hypoxia associated genes and inflammatory cytokine profiling in COPD-PH
P Choudhury, S Dasgupta, A Kar, S Sarkar… - Respiratory …, 2024 - Elsevier
67 天前 - … of disease specific diagnostic/therapeutic targets and … /molecular markers and
disease associated pathways. The … growth factor β (TGF-β), interleukin 1-beta (IL-1β), IL-4, IL-5, IL-…
disease associated pathways. The … growth factor β (TGF-β), interleukin 1-beta (IL-1β), IL-4, IL-5, IL-…
IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction
J Huang, W Kuang, Z Zhou - Inflammopharmacology, 2024 - Springer
72 天前 - … of the inflammatory factor interleukin-1 (IL-1) in atherosclerosis. Targeted IL-1
therapy … These findings suggest that TNFR2 may have a protective role against heart failure. …
therapy … These findings suggest that TNFR2 may have a protective role against heart failure. …
ROLE OF IMMUNOTHERAPY IN CARDIOVASCULAR DISEASES
A Maklai - dea.lib.unideb.hu
77 天前 - … of the arteries, is the primary cause of the majority of CVD problems… cardiovascular
disease caused by atherosclerosis is anti-IL-1 antibody therapy (canakinumab). Interleukin-1 …
disease caused by atherosclerosis is anti-IL-1 antibody therapy (canakinumab). Interleukin-1 …
Rescue of cardiac dysfunction during chemotherapy in acute myeloid leukaemia by blocking IL-1α
X Zhou, Y Liu, Y Shen, L Chen, W Hu… - European Heart …, 2024 - academic.oup.com
87 天前 - … -derived interleukin 1 alpha (IL-1α) disrupted cardiac metabolism, leading to impaired
… Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. …
… Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. …
相关搜索
- heart failure rationale and design
- coronary artery disease
- therapeutic target in cardiovascular disease
- targeted therapies cardiovascular disease
- risks of cardiovascular disease and diabetes
- colchicine in stable chronic heart failure
- atherothrombotic cardiovascular diseases
- risk factor for cardiovascular disease
- colchicine in cardiovascular disease
- allele associates coronary artery disease risk
- immune therapeutic approaches cardiovascular diseases
- immunotherapeutic approaches cardiovascular diseases
- role of immunotherapy cardiovascular diseases
- genetics of lipoprotein cardiovascular disease
- lower lipoprotein coronary artery disease risk
- anti-inflammatory treatment stable chronic heart failure